Enlivex Therapeutics Stock Forecast

Sell candidate since Jul 13, 2026 Loss -68.67%

The Enlivex Therapeutics Ltd. stock price gained 7.18% on the last trading day (Friday, 31st Jul 2026), rising from $1.95 to $2.09. During the last trading day the stock fluctuated 17.39% from a day low at $1.84 to a day high of $2.16. The price has fallen in 6 of the last 10 days and is down by -55.34% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 29 thousand more shares were traded than the day before. In total, 339 thousand shares were bought and sold for approximately $707.69 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.79 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -59.34% during the next 3 months and, with a 90% probability hold a price between $0.730 and $2.65 at the end of this 3-month period.

ENLV Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 30, 2026, and so far it has risen 7.18%. Further rise is indicated until a new top pivot has been found. Enlivex Therapeutics Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Enlivex Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.05 and $6.76. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Enlivex Therapeutics Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.95. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.320 between high and low, or 17.39%. For the last week, the stock has had daily average volatility of 44.96%.

Enlivex Therapeutics Ltd. is oversold on RSI14 (6). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ENLV) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Enlivex Therapeutics Ltd. to open at $2.03, and during the day (based on 14 day Average True Range), to move between $1.72 and $2.46, which gives a possible trading interval of +/-$0.741 (+/-43.10%) up or down from last closing price. If Enlivex Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 43.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.95 (6.70%) than the resistance at $2.24 (7.18%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Enlivex Therapeutics Ltd. stock A Buy?

Enlivex Therapeutics Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.109 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $2.03 ( 2.87%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk